Invivyd (IVVD) Return on Capital Employed (QoQ) (2022 - 2025)
Invivyd (IVVD) Return on Capital Employed (QoQ) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn |
| 10 | Invivyd | 104.86 Mn | -121.83 Mn | 16.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5,739.00 |
| Sep 30, 2025 | 12,900.00 |
| Jun 30, 2025 | 199.00 |
| Mar 31, 2025 | -913.00 |
| Dec 31, 2024 | 4,611.00 |
| Sep 30, 2024 | -12,260.00 |
| Jun 30, 2024 | -1,655.00 |
| Mar 31, 2024 | -1,272.00 |
| Dec 31, 2023 | -3,681.00 |
| Sep 30, 2023 | -591.00 |
| Jun 30, 2023 | -868.00 |
| Mar 31, 2023 | 1,141.00 |
| Dec 31, 2022 | 379.00 |
| Sep 30, 2022 | -384.00 |
| Jun 30, 2022 | -675.00 |
| Mar 31, 2022 | -2,026.00 |